Symbyax Lawsuit

A Brief Guide to Filing a Symbyax Lawsuit:

Symbyax Side Effects:

Administered to patients with bipolar disorder and depression, the prescription medication Symbyax, because of its side effects, has long been the subject of controversy. However, to date no significant Symbyax lawsuit—and subsequent settlement--has been made public. In response to numerous Symbyax lawsuits, the Eli Lilly and Company (manufacturer of Symbyax) has instituted an assortment of warnings in an attempt to reduce overall liability.

Symbyax combines two different active ingredients: olanzapine and fluoxetine. While post-market studies regarding Symbyax side effects have not yet been conducted, there is some evidence that olanzapine poses significant risks.

Nearly 24,000 suits regarding olanzapine in the form of the medication Zyprexa have been settled. This information will ultimately affect your prospective Symbyax lawsuit.
Symbyax side effects may arise regardless of adherence to dosage instructions. Please seek medical treatment if you experience any of the following side effects:

• Increased Triglycerides: experienced in up to 68 percent of patients

• Increased Cholesterol Levels: experienced in up to 35 percent of patients

• Weight Gain: experienced in up to 25 percent of patients

• Increased appetite: experienced in up to 20 percent of patients

• Dry Mouth: experienced in up to 15 percent of patients

• Fatigue: experienced in up to 12 percent of patients

Like other antidepressant, there is a risk of suicidal impulses in patients 24 or younger. In 2007, the FDA mandated that a warning of such possibilities be included with all antidepressants.

Symbyax Lawsuits: FDA Regulations

In 2011, the United States Food and Drug Administration issued a mandate concerning Symbyax side effects on newborns. Use of antipsychotics in the third trimester of pregnancy was determined to pose an increased risk of birth defects, including withdrawal symptoms in newborns.

Often a change in an FDA warning label compels patients to file a Symbyax lawsuit. Patients experiencing adverse reactions may seek Symbyax lawsuits to compensate for medical costs, pain and suffering and lost wages. The primary grounds for a Symbyax lawsuit alleges the manufacturer of failing to adequately warn consumers concerning the risks of taking the medication. To be upheld, these Symbyax lawsuits must definitively prove that Symbyax-use caused the plaintiff’s injury or medical harm. Failure to affirm such a link would result in a faulty Symbyax lawsuit.

There are several notable Symbyax side effects that can form grounds for Symbyax lawsuits. Withdrawal symptoms, including unusual muscle movements (extrapyramidal signs), birth defects and suicide are the most common grounds for initiating Symbyax lawsuits.

Women who gave birth to a child demonstrating these symptoms are file Symbyax lawsuits. Similarly, the development of many heart conditions and spina bifida could also be grounds to pursue a Symbyax lawsuit.

If you are a woman who gave birth to a child with birth defects before the 2011 warning update, it is important to act quickly to pursue a Symbyax settlement. While in some states you will still be within the statute of limitations for a Symbyax lawsuit, it takes time to assemble a strong case. Documentation is required to affirm the formation of Symbyax side effects. For an attorney to pursue a strong Symbyax lawsuit, it will be helpful if multiple plaintiffs combine similar complaints into a class action filing.

Sources:

1.http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/

DrugSafetyInformationforHeathcareProfessionals/ucm085288.htm

2.http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089140.pdf

3. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021520s017lbl.pdf